Sept. 23, 2019
Professor published in Health Policy journal
"How will recent trade agreements that extend market protections for brand-name prescription pharmaceuticals impact expenditures and generic access in Canada?" looks for an analytic approach that can assess more than one change to a country’s market protections and then to apply this methodology to the Canadian context.
Lorian co-authored the paper with Reed Beall and Fiona Clement of the O'Brien Institute of Public Health, and Aidan Hollis of UCalgary's Department of Economics.